INTRAVENOUS ADMINISTRATION OF INDOKLON® 10% SOLUTION
Abstract
A group of 14 psychotic patients displaying depressive and schizo-affective symptomatology who had not responded to psychotropic drug therapies were treated with a 10% solution of Indoklon administered intravenously. The patients received a total of 85 treatments. Observations indicated that administration of the 10% solution brought about symptomatic improvement similar to that which would have been obtained with ECT. Administration of the 10% solution appears to be essentially free of the complaints associated with the 5% solution previously used.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).